Research Methods: Quality of Life and Patient-Reported Outcome Research in Geriatric Oncology

Living reference work entry

Abstract

Both clinical care for and clinical research in older patients with cancer need to define endpoints of treatment. Clinical research in geriatric oncology aims to improve the care for older adults with cancer. When asking older adults with cancer what they consider most important as aim of their treatment, some will focus more on lengths and others more on quality of life. Whereas it is easy to measure length of survival, it is more difficult to measure quality of life. As variety of quality of life assessment instruments is available, some of them are addressing health-related quality of life in general; some are developed in a disease-specific background, such as cancer; and others focus on special types of cancer or special kinds of cancer treatment. In the context of older adults with cancer, geriatric assessment is established to address areas of resources and limitations. Those items of geriatric assessment reported by the patient or demonstrated in performance test should be considered as patient-reported outcomes as well. Results of geriatric assessment and of health-related quality of life are closely related in older adults with cancer.

References

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMedGoogle Scholar
  2. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M, PRO Harmonization Group. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522–31.CrossRefPubMedGoogle Scholar
  3. Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gonen M, Schrag D, Basch E. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012;21(7):1159–64.CrossRefPubMedGoogle Scholar
  4. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9).  https://doi.org/10.1093/jnci/dju244.
  5. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRefPubMedGoogle Scholar
  6. Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, Lober WB, Bush NE, Parvathaneni U, Back AL, Amtmann D, Ford R. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014a;32(3):199–205.CrossRefPubMedGoogle Scholar
  7. Berry DL, Hong F, Halpenny B, Partridge A, Fox E, Fann JR, Wolpin S, Lober WB, Bush N, Parvathaneni U, Amtmann D, Ford R. The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 2014b;14:513.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Camuso N, Bajaj P, Dudgeon D, Mitera G. Engaging patients as Partners in Developing Patient-Reported Outcome Measures in cancer-a review of the literature. Support Care Cancer. 2016;24(8):3543–9.CrossRefPubMedGoogle Scholar
  9. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.CrossRefPubMedGoogle Scholar
  10. Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart MJ, Sidransky D, Soussan-Gutman L, Tziraki C. Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics". J Natl Cancer Inst. 2014;106(12).  https://doi.org/10.1093/jnci/dju321.
  11. Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, Gridelli C, Gebbia V, Ciardiello F, De Placido S, Ceribelli A, Favaretto AG, de Matteis A, Feld R, Butts C, Bryce J, Signoriello S, Morabito A, Rocco G, Perrone F. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910–5.CrossRefPubMedGoogle Scholar
  12. Esbensen BA, Osterlind K, Roer O, Hallberg IR. Quality of life of elderly persons with newly diagnosed cancer. Eur J Cancer Care. 2004;13(5):443–53.CrossRefGoogle Scholar
  13. Fitzsimmons D. What are we trying to measure? Rethinking approaches to health outcome assessment for the older person with cancer. Eur J Cancer Care. 2004;13(5):416–23.CrossRefGoogle Scholar
  14. Fitzsimmons D, Gilbert J, Howse F, Young T, Arrarras JI, Bredart A, Hawker S, George S, Aapro M, Johnson CD. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur J Cancer. 2009;45(1):19–32.CrossRefPubMedGoogle Scholar
  15. Gravanis I, Lopez AS, Hemmings RJ, Jimenez JC, Garcia-Carbonero R, Gallego IG, Gimenez EV, O'Connor D, Giuliani R, Salmonson T, Pignatti F. The European medicines agency review of abiraterone for the treatment of metastatic castration-resistant prostate cancer in adult men after docetaxel chemotherapy and in chemotherapy-naive disease: summary of the scientific assessment of the committee for medicinal products for human use. Oncologist. 2013;18(9):1032–42.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP. Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer. 2004;101(2):404–11.CrossRefPubMedGoogle Scholar
  17. Jensen RE, Snyder CF. PRO-cision medicine: personalizing patient care using patient-reported outcomes. J Clin Oncol. 2016;34(6):527–9.CrossRefPubMedGoogle Scholar
  18. Johnson C, Fitzsimmons D, Gilbert J, Arrarras JI, Hammerlid E, Bredart A, Ozmen M, Dilektasli E, Coolbrandt A, Kenis C, Young T, Chow E, Venkitaraman R, Howse F, George S, O'Connor S, Yadegarfar G, EORTC Quality of Life Group. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: the EORTC QLQ-ELD15. Eur J Cancer. 2010;46(12):2242–52.CrossRefPubMedGoogle Scholar
  19. Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Am Soc Clin Oncol Educ Book. 2016;35:67–73.CrossRefPubMedGoogle Scholar
  20. Kyte D, Reeve BB, Efficace F, Haywood K, Mercieca-Bebber R, King MT, Norquist JM, Lenderking WR, Snyder C, Ring L, Velikova G, Calvert M. International Society for Quality of life research commentary on the draft European medicines agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. Qual Life Res. 2016;25(2):359–62.CrossRefPubMedGoogle Scholar
  21. Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, Castro KM, Denicoff A, Rogak LJ, Piekarz RL, Cleeland CS, Sloan JA, Schrag D, Basch E. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017;14(3):255–63.CrossRefPubMedGoogle Scholar
  22. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol. 1999;17(11):3621–30.CrossRefPubMedGoogle Scholar
  23. Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7).  https://doi.org/10.1093/jnci/dju129.
  24. Saad IA, Botega NJ, Toro IF. Evaluation of quality of life of patients submitted to pulmonary resection due to neoplasia. J Bras Pneumol. 2006;32(1):10–5.CrossRefPubMedGoogle Scholar
  25. Strasser F, Blum D, von Moos R, Cathomas R, Ribi K, Aebi S, Betticher D, Hayoz S, Klingbiel D, Brauchli P, Haefner M, Mauri S, Kaasa S, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Ann Oncol. 2016;27(2):324–32.CrossRefPubMedGoogle Scholar
  26. Thome B, Dykes AK, Hallberg IR. Quality of life in old people with and without cancer. Qual Life Res. 2004;13(6):1067–80.CrossRefPubMedGoogle Scholar
  27. VanderWalde NA, Deal AM, Comitz E, Stravers L, Muss H, Reeve BB, Basch E, Tepper J, Chera B. Geriatric assessment as a predictor of tolerance, quality of life, and outcomes in older patients with head and neck cancers and lung cancers receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2017;98(4):850–7.CrossRefPubMedGoogle Scholar
  28. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–24.CrossRefPubMedGoogle Scholar
  29. Wedding U, Pientka L, Hoffken K. Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer. 2007a;43(15):2203–10.CrossRefPubMedGoogle Scholar
  30. Wedding U, Rohrig B, Klippstein A, Brix C, Pientka L, Hoffken K. Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients. Support Care Cancer. 2007b;15(9):1097–104.CrossRefPubMedGoogle Scholar
  31. Wedding U, Rohrig B, Klippstein A, Pientka L, Hoffken K. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol. 2007c;133(12):945–50.CrossRefPubMedGoogle Scholar
  32. Wedding U, Koch A, Rohrig B, Pientka L, Sauer H, Hoffken K, Maurer I. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol. 2008;47(1):56–62.CrossRefPubMedGoogle Scholar
  33. Wheelwright S, Darlington AS, Fitzsimmons D, Fayers P, Arraras JI, Bonnetain F, Brain E, Bredart A, Chie WC, Giesinger J, Hammerlid E, O'Connor SJ, Oerlemans S, Pallis A, Reed M, Singhal N, Vassiliou V, Young T, Johnson C. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Br J Cancer. 2013;109(4):852–8.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Wildiers H, Mauer M, Pallis A, Hurria A, Mohile SG, Luciani A, Curigliano G, Extermann M, Lichtman SM, Ballman K, Cohen HJ, Muss H, Wedding U. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer – alliance for clinical trials in oncology – international society of geriatric oncology position article. J Clin Oncol. 2013;31(29):3711–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Palliative Care within the Department of Hematology and OncologyUniversity Hospital of JenaJenaGermany

Section editors and affiliations

  • Tamas Fulop
    • 1
  • Martine Extermann
    • 2
  1. 1.Division of Geriatric Medicine, Department of Medicine, Research Center on AgingUniversité de SherbrookeQCCanada
  2. 2.Senior Adult Oncology Program, Moffitt Cancer CenterUniversity of South FloridaTampaUSA

Personalised recommendations